Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
crosses cell membranes readily Metabolism: Hepatic metabolism Elimination: Renal excretion Half-Life: Approximately 4-6 hours (estimated) Quality Specifications Testing Standards: HPLC purity verification Mass spectrometry confirmation Endotoxin testing Heavy metal screening Microbial contamination testing Certificate of Analysis (COA): Batch-specific purity data Identity confirmation Contaminant screening results Storage and handling recommendations Reconstitution Specifications Recommended Diluent: Bacteriostatic Water (0.9% benzyl alcohol) Standard Concentration: 100mg/ml (2ml Bacteriostatic Water per 200mg vial) Alternative Concentrations: 50mg/ml or 200mg/ml based on preference Reconstitution Time: 2-3 minutes with gentle swirling Solution Appearance: Clear, colorless solution pH Range: 5.0-7.0 (physiologically compatible) Administration Specifications Injection Type: Subcutaneous Needle Gauge: 29-31 gauge Needle Length: 12.7mm (1/2 inch) Injection Volume: 0.5-1.0ml per dose Injection Sites: Abdomen, thighs, upper arms Injection Frequency: Once daily (standard protocol) Storage Specifications Unreconstituted Storage: Temperature: 20-25C (68-77F) room temperature Light: Protect from direct light Humidity: Store in dry environment Duration: 2-3 years Reconstituted Storage: Temperature: 2-8C (36-46F) refrigerated Light: Protect from light (amber vial or original packaging) Duration: 30 days maximum Freezing: Do not freeze Safety and Handling Personal Protective Equipment: Gloves recommended during reconstitution Standard laboratory safety practices Proper sharps disposal procedures Disposal: Dispose of needles in approved sharps container Discard expired or contaminated product appropriately Follow local regulations for pharmaceutical waste Research Applications Primary Research Areas: Obesity and metabolic syndrome Type 2 diabetes and insulin resistance Cellular aging and longevity Mitochondrial function and energy metabolism NAD+ biology and supplementation Preclinical Models: Diet-induced obesity models Metabolic dysfunction studies Aging research Cellular metabolism investigations RELATED PRODUCTS AND COMPLEMENTARY THERAPIES Synergistic Peptides and Compounds NAD+ Precursors: Nicotinamide Mononucleotide (NMN) Nicotinamide Riboside (NR) May enhance 5-amino-1MQ effects through complementary NAD+ support GLP-1 Agonists: Semaglutide Tirzepatide Complementary appetite control with metabolic enhancement Ipamorelin CJC-1295 Support muscle preservation and metabolic function Metformin Berberine Enhance insulin sensitivity and glucose metabolism Complementary Supplements Essential Supplements: Omega-3 fatty acids (EPA/DHA) Vitamin D3 Magnesium Multivitamin/mineral complex Performance Supplements: Creatine monohydrate Beta-alanine L-carnitine Coenzyme Q10 Recovery Supplements: Branched-chain amino acids (BCAAs) Glutamine Collagen peptides Electrolyte formulations Lifestyle Optimization Strategies Nutrition Protocols: High-protein diet (0.8-1.0g per pound body weight) Moderate caloric deficit for fat loss Intermittent fasting protocols Whole food, minimally processed diet Exercise Programs: Resistance training (3-4x per week) Cardiovascular exercise (2-3x per week) High-intensity interval training (HIIT) Active recovery and mobility work Recovery Optimization: Sleep optimization (7-9 hours nightly) Stress management techniques Cold therapy and heat therapy Massage and bodywork Medical Monitoring and Testing Recommended Baseline Testing: Complete metabolic panel Lipid panel Fasting glucose and insulin Hemoglobin A1C Thyroid function tests Body composition analysis Progress Monitoring: Monthly body composition assessments Quarterly metabolic panel updates Regular blood pressure monitoring Waist circumference measurements Progress photos and measurements COMPLIANCE AND LEGAL INFORMATION Regulatory Status 5-Amino-1MQ is not approved by the FDA for any medical use and is sold as a research compound only
Gout There are some limited studies in patients with gout, some reporting a possible flare of gout when therapy with GLP1 is started, mostly due to rapid weight loss and dehydration that may precipitate gout attacks
Our state-of-the-art facility in Scarsdale features services that offer the latest technologies in anti-aging, body sculpting, skin resurfacing, laser treatments, and more
A different study found that semaglutide users had less joint pain, stiffness, and swelling than those not taking it
This copper-binding tripeptide naturally occurs in human plasma, though levels decline substantially with age
Mitsi E, Diniz MO, Rein J, Collins AM, Robinson RE, Hyder-Wright A, et al
